Impact of Transplant Type on Infection Risk in Studies of Neutropenic Diets
T
Takashi Miyachi
(Takashi Miyachi, MD; Akihiro Kitadate, MD, PhD; and Masahiro Kami, MD, PhD, Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan; and Medical Governance Research Institute, Tokyo, Japan)
A
Akihiro Kitadate
(1Akita University Graduate School of Medicine, Department of Hematology, Nephrology, and Rheumatology, Akita, Japan)
M
Masahiro Kami
(Takashi Miyachi, MD; Akihiro Kitadate, MD, PhD; and Masahiro Kami, MD, PhD, Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan; and Medical Governance Research Institute, Tokyo, Japan)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 44, Issue 22
Published
August 01, 2026
Pages
2159-2160
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (3)
T
Takashi Miyachi
Takashi Miyachi, MD; Akihiro Kitadate, MD, PhD; and Masahiro Kami, MD, PhD, Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan; and Medical Governance Research Institute, Tokyo, Japan
A
Akihiro Kitadate
1Akita University Graduate School of Medicine, Department of Hematology, Nephrology, and Rheumatology, Akita, Japan
M
Masahiro Kami
Takashi Miyachi, MD; Akihiro Kitadate, MD, PhD; and Masahiro Kami, MD, PhD, Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan; and Medical Governance Research Institute, Tokyo, Japan
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001